Keefer LK - Search Results

1

Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation.

Liu J, Li C, Qu W, Leslie E, Bonifant CL, Buzard GS, Saavedra JE, Keefer LK, Waalkes MP. Liu J, et al. Among authors: keefer lk. Mol Cancer Ther. 2004 Jun;3(6):709-14. Mol Cancer Ther. 2004. PMID: 15210857

2

The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice.

Liu J, Li C, Waalkes MP, Clark J, Myers P, Saavedra JE, Keefer LK. Liu J, et al. Among authors: keefer lk. Hepatology. 2003 Feb;37(2):324-33. doi: 10.1053/jhep.2003.50063. Hepatology. 2003. PMID: 12540782

3

JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity.

Shami PJ, Saavedra JE, Wang LY, Bonifant CL, Diwan BA, Singh SV, Gu Y, Fox SD, Buzard GS, Citro ML, Waterhouse DJ, Davies KM, Ji X, Keefer LK. Shami PJ, et al. Among authors: keefer lk. Mol Cancer Ther. 2003 Apr;2(4):409-17. Mol Cancer Ther. 2003. PMID: 12700285

4

The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced nephrotoxicity in mice.

Li C, Liu J, Saavedra JE, Keefer LK, Waalkes MP. Li C, et al. Among authors: keefer lk. Toxicology. 2003 Aug 1;189(3):173-80. doi: 10.1016/s0300-483x(03)00129-x. Toxicology. 2003. PMID: 12832150

5

Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug.

Findlay VJ, Townsend DM, Saavedra JE, Buzard GS, Citro ML, Keefer LK, Ji X, Tew KD. Findlay VJ, et al. Among authors: keefer lk. Mol Pharmacol. 2004 May;65(5):1070-9. doi: 10.1124/mol.65.5.1070. Mol Pharmacol. 2004. PMID: 15102935 Free PMC article.

6

The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular level.

Qu W, Liu J, Fuquay R, Shimoda R, Sakurai T, Saavedra JE, Keefer LK, Waalkes MP. Qu W, et al. Among authors: keefer lk. Nitric Oxide. 2005 Mar;12(2):114-20. doi: 10.1016/j.niox.2005.01.005. Nitric Oxide. 2005. PMID: 15740985

7

The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis.

Qu W, Liu J, Fuquay R, Saavedra JE, Keefer LK, Waalkes MP. Qu W, et al. Among authors: keefer lk. Cancer Lett. 2007 Oct 28;256(2):238-45. doi: 10.1016/j.canlet.2007.06.009. Epub 2007 Jul 20. Cancer Lett. 2007. PMID: 17658681 Free PMC article.

8

V-PROLI/NO, a prodrug of the nitric oxide donor, PROLI/NO.

Chakrapani H, Showalter BM, Kong L, Keefer LK, Saavedra JE. Chakrapani H, et al. Among authors: keefer lk. Org Lett. 2007 Aug 16;9(17):3409-12. doi: 10.1021/ol701419a. Epub 2007 Jul 20. Org Lett. 2007. PMID: 17658755

9

Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs.

Chakrapani H, Maciag AE, Citro ML, Keefer LK, Saavedra JE. Chakrapani H, et al. Among authors: keefer lk. Org Lett. 2008 Nov 20;10(22):5155-8. doi: 10.1021/ol8020989. Epub 2008 Oct 29. Org Lett. 2008. PMID: 18956868 Free PMC article.

10

V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity.

Qu W, Liu J, Dill AL, Saavedra JE, Keefer LK, Waalkes MP. Qu W, et al. Among authors: keefer lk. Cancer Sci. 2009 Mar;100(3):382-8. doi: 10.1111/j.1349-7006.2008.01050.x. Epub 2008 Dec 15. Cancer Sci. 2009. PMID: 19154403 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters